Role of transmethylation reactions in alcoholic liver disease

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Alcoholic liver disease is a major health care problem worldwide. Findings from many laboratories, including ours, have demonstrated that ethanol feeding impairs several of the many steps involved in methionine metabolism. Ethanol consumption predominantly results in a decrease in the hepatocyte level of S-adenosylmethionine and the increases in two toxic metabolites, homocysteine and S-adenosylhomocysteine. These changes, in turn, result in serious functional consequences which include decreases in essential methylation reactions via inhibition of various methyltransferases. Of particular interest to our laboratory is the inhibition of three important enzymes, phosphatidylethanolamine methyltransferase, isoprenylcysteine carboxyl methyltransferase and protein L-isoaspartate methyltransferase. Decreased activity of these enzymes results in increased fat deposition, increased apoptosis and increased accumulation of damaged proteins-all of which are hallmark features of alcoholic liver injury. Of all the therapeutic modalities available, betaine has been shown to be the safest, least expensive and most effective in attenuating ethanol-induced liver injury. Betaine, by virtue of aiding in the remethylation of homocysteine, removes both toxic metabolites (homocysteine and S-adenosylhomocysteine), restores S-adenosylmethionine level, and reverses steatosis, apoptosis and damaged proteins accumulation. In conclusion, betaine appears to be a promising therapeutic agent in relieving the methylation and other defects associated with alcoholic abuse.

Original languageEnglish (US)
Pages (from-to)4947-4954
Number of pages8
JournalWorld Journal of Gastroenterology
Volume13
Issue number37
DOIs
StatePublished - Oct 7 2007

Fingerprint

Betaine
Alcoholic Liver Diseases
Homocysteine
S-Adenosylhomocysteine
S-Adenosylmethionine
Ethanol
Poisons
Methylation
Protein D-Aspartate-L-Isoaspartate Methyltransferase
Phosphatidylethanolamine N-Methyltransferase
Apoptosis
Liver
Wounds and Injuries
Methyltransferases
Enzymes
Methionine
Hepatocytes
Proteins
Fats
Delivery of Health Care

Keywords

  • Alcohol
  • Apoptosis
  • Betaine
  • Liver
  • Methyltransferases
  • S-adenosylhomocysteine
  • Steatosis
  • Transmethylation

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Role of transmethylation reactions in alcoholic liver disease. / Kharbanda, Kusum.

In: World Journal of Gastroenterology, Vol. 13, No. 37, 07.10.2007, p. 4947-4954.

Research output: Contribution to journalArticle

@article{a6d4137d2bec4e5b9ab19d7c722c839b,
title = "Role of transmethylation reactions in alcoholic liver disease",
abstract = "Alcoholic liver disease is a major health care problem worldwide. Findings from many laboratories, including ours, have demonstrated that ethanol feeding impairs several of the many steps involved in methionine metabolism. Ethanol consumption predominantly results in a decrease in the hepatocyte level of S-adenosylmethionine and the increases in two toxic metabolites, homocysteine and S-adenosylhomocysteine. These changes, in turn, result in serious functional consequences which include decreases in essential methylation reactions via inhibition of various methyltransferases. Of particular interest to our laboratory is the inhibition of three important enzymes, phosphatidylethanolamine methyltransferase, isoprenylcysteine carboxyl methyltransferase and protein L-isoaspartate methyltransferase. Decreased activity of these enzymes results in increased fat deposition, increased apoptosis and increased accumulation of damaged proteins-all of which are hallmark features of alcoholic liver injury. Of all the therapeutic modalities available, betaine has been shown to be the safest, least expensive and most effective in attenuating ethanol-induced liver injury. Betaine, by virtue of aiding in the remethylation of homocysteine, removes both toxic metabolites (homocysteine and S-adenosylhomocysteine), restores S-adenosylmethionine level, and reverses steatosis, apoptosis and damaged proteins accumulation. In conclusion, betaine appears to be a promising therapeutic agent in relieving the methylation and other defects associated with alcoholic abuse.",
keywords = "Alcohol, Apoptosis, Betaine, Liver, Methyltransferases, S-adenosylhomocysteine, Steatosis, Transmethylation",
author = "Kusum Kharbanda",
year = "2007",
month = "10",
day = "7",
doi = "10.3748/wjg.v13.i37.4947",
language = "English (US)",
volume = "13",
pages = "4947--4954",
journal = "World Journal of Gastroenterology",
issn = "1007-9327",
publisher = "WJG Press",
number = "37",

}

TY - JOUR

T1 - Role of transmethylation reactions in alcoholic liver disease

AU - Kharbanda, Kusum

PY - 2007/10/7

Y1 - 2007/10/7

N2 - Alcoholic liver disease is a major health care problem worldwide. Findings from many laboratories, including ours, have demonstrated that ethanol feeding impairs several of the many steps involved in methionine metabolism. Ethanol consumption predominantly results in a decrease in the hepatocyte level of S-adenosylmethionine and the increases in two toxic metabolites, homocysteine and S-adenosylhomocysteine. These changes, in turn, result in serious functional consequences which include decreases in essential methylation reactions via inhibition of various methyltransferases. Of particular interest to our laboratory is the inhibition of three important enzymes, phosphatidylethanolamine methyltransferase, isoprenylcysteine carboxyl methyltransferase and protein L-isoaspartate methyltransferase. Decreased activity of these enzymes results in increased fat deposition, increased apoptosis and increased accumulation of damaged proteins-all of which are hallmark features of alcoholic liver injury. Of all the therapeutic modalities available, betaine has been shown to be the safest, least expensive and most effective in attenuating ethanol-induced liver injury. Betaine, by virtue of aiding in the remethylation of homocysteine, removes both toxic metabolites (homocysteine and S-adenosylhomocysteine), restores S-adenosylmethionine level, and reverses steatosis, apoptosis and damaged proteins accumulation. In conclusion, betaine appears to be a promising therapeutic agent in relieving the methylation and other defects associated with alcoholic abuse.

AB - Alcoholic liver disease is a major health care problem worldwide. Findings from many laboratories, including ours, have demonstrated that ethanol feeding impairs several of the many steps involved in methionine metabolism. Ethanol consumption predominantly results in a decrease in the hepatocyte level of S-adenosylmethionine and the increases in two toxic metabolites, homocysteine and S-adenosylhomocysteine. These changes, in turn, result in serious functional consequences which include decreases in essential methylation reactions via inhibition of various methyltransferases. Of particular interest to our laboratory is the inhibition of three important enzymes, phosphatidylethanolamine methyltransferase, isoprenylcysteine carboxyl methyltransferase and protein L-isoaspartate methyltransferase. Decreased activity of these enzymes results in increased fat deposition, increased apoptosis and increased accumulation of damaged proteins-all of which are hallmark features of alcoholic liver injury. Of all the therapeutic modalities available, betaine has been shown to be the safest, least expensive and most effective in attenuating ethanol-induced liver injury. Betaine, by virtue of aiding in the remethylation of homocysteine, removes both toxic metabolites (homocysteine and S-adenosylhomocysteine), restores S-adenosylmethionine level, and reverses steatosis, apoptosis and damaged proteins accumulation. In conclusion, betaine appears to be a promising therapeutic agent in relieving the methylation and other defects associated with alcoholic abuse.

KW - Alcohol

KW - Apoptosis

KW - Betaine

KW - Liver

KW - Methyltransferases

KW - S-adenosylhomocysteine

KW - Steatosis

KW - Transmethylation

UR - http://www.scopus.com/inward/record.url?scp=34848888039&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34848888039&partnerID=8YFLogxK

U2 - 10.3748/wjg.v13.i37.4947

DO - 10.3748/wjg.v13.i37.4947

M3 - Article

C2 - 17854136

AN - SCOPUS:34848888039

VL - 13

SP - 4947

EP - 4954

JO - World Journal of Gastroenterology

JF - World Journal of Gastroenterology

SN - 1007-9327

IS - 37

ER -